HMV Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
948
+91
+11% +$93K 0.44% 34
2026
Q1
$788K Buy
857
+39
+5% +$39.5K 0.37% 36
2025
Q4
$879K Hold
818
0.44% 34
2025
Q3
$624K Sell
818
-27
-3% -$20.1K 0.34% 42
2025
Q2
$659K Sell
845
-759
-47% -$590K 0.43% 40
2025
Q1
$1.32M Hold
1,604
1.05% 28
2024
Q4
$1.24M Buy
+1,604
New +$1.33M 1.24% 29

Other funds holding LLY

HMV Wealth Advisors's LLY Position: Q2 2026 in Review

HMV Wealth Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $93K and bringing the position to 948 shares worth $1.14M. The position accounts for 0.44% of the portfolio, ranked #34.

HMV Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.32M in Q1 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HMV Wealth Advisors held 948 shares of Eli Lilly worth $1.14M as of Q2 2026.
  • HMV Wealth Advisors bought 91 Eli Lilly shares in Q2 2026, an estimated $93K.
  • Eli Lilly made up 0.44% of HMV Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • HMV Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • HMV Wealth Advisors's Eli Lilly position peaked at $1.32M in Q1 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HMV Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.